Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Amortization of Deferred Charges: 2020-2023

Historic Amortization of Deferred Charges for Journey Medical (DERM) over the last 4 years, with Dec 2023 value amounting to $353,000.

  • Journey Medical's Amortization of Deferred Charges fell 11.94% to $177,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $504,000, marking a year-over-year decrease of 35.71%. This contributed to the annual value of $353,000 for FY2023, which is 54.16% down from last year.
  • According to the latest figures from FY2023, Journey Medical's Amortization of Deferred Charges is $353,000, which was down 54.16% from $770,000 recorded in FY2022.
  • Over the past 5 years, Journey Medical's Amortization of Deferred Charges peaked at $781,000 during FY2021, and registered a low of $353,000 during FY2023.
  • For the 3-year period, Journey Medical's Amortization of Deferred Charges averaged around $634,667, with its median value being $770,000 (2022).
  • Per our database at Business Quant, Journey Medical's Amortization of Deferred Charges climbed by 11.89% in 2021 and then crashed by 54.16% in 2023.
  • Over the past 4 years, Journey Medical's Amortization of Deferred Charges (Yearly) stood at $698,000 in 2020, then grew by 11.89% to $781,000 in 2021, then dropped by 1.41% to $770,000 in 2022, then slumped by 54.16% to $353,000 in 2023.